NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001497

Registered date:11/11/2008

Midazolam v.s. propofol for sedaion in endoscopic submucosal dissection; a randomized phase II trial. KDOG0801

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedearly gastric cancer, gastric adenoma
Date of first enrollment2008/07/01
Target sample size138
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)sedation with propofol sedation with midazolam

Outcome(s)

Primary Outcomethe efficacy of sedation enough for endoscopic submucosal dissection.
Secondary Outcomethe safety of sedation during endoscopic submucosal dissection. the sagety of sadation after endoscopic submucosal dissection.

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaASA classification:above III. severe disease in heart, lung, liver, or kidney. allergic episode with midazolam or propofol. women in pregnancy or breast-feeding any other reasosn by which docter judged inappropriate case.

Related Information

Contact

public contact
Name Tohru SASAKI
Address Asamizodai2-1-1, Sagamihra, Kanagawa Japan
Telephone 042-748-9111
E-mail tohrus@t3.rim.or.jp
Affiliation Kitasato University East Hospital Department of gastroenterology
scientific contact
Name Satoshi TANABE
Address Asamizodai2-1-1,Sagamihara, Kanagawa Japan
Telephone 042-748-9111
E-mail
Affiliation Kitasato University East Hospital Department of gastroenterology